Aspen Dental, one of the largest DSOs in the United States, has completed a full-scale deployment of clinical AI across its entire network of more than 1,100 practices in just six weeks — a pace that ranks among the fastest enterprise AI rollouts in the history of organized dentistry.
The Chicago-based DSO, operated by The Aspen Group (TAG), announced on February 3, 2026 that it had selected VideaHealth’s Clinical Assist AI platform. By February 10, TAG confirmed that the deployment — branded internally as “Aspen Intelligence” — was live across all offices, reaching more than 2,000 dentists nationwide.
Six Weeks From Launch to Full Deployment
While the six-week rollout timeline made headlines, TAG leadership was quick to note that the compressed deployment phase was preceded by months of preparation and piloting. During the pilot period, participating practices observed a 12% increase in treatment acceptance — a metric that helped build internal confidence in expanding the platform system-wide.
“Innovation has always been part of our DNA — not innovation for its own sake, but innovation that strengthens both clinical confidence in providers and their ability to deliver the best patient care,” said Dr. Arwinder Judge, Chief Clinical Officer at TAG.
The deployment followed a structured approach that prioritized clinician training on both platform functionality and patient-facing conversations about AI-assisted diagnostics. Rather than replacing existing workflows, the AI was integrated as a clinical support layer — preserving dentist autonomy while offering a secondary analysis of radiographic images.
Data protection was embedded within Aspen’s existing IT and cybersecurity framework, an implementation detail that TAG highlighted as essential for a healthcare organization operating at this scale.
Aspen Intelligence: A First in DSO Branding
Aspen Dental is the first major DSO to brand its AI deployment with a proprietary name. The “Aspen Intelligence” label signals a strategic decision to position clinical AI not as a third-party add-on, but as an integrated part of the Aspen patient experience.
The branding move suggests TAG views AI as a long-term competitive differentiator rather than a transient technology experiment — and it may prompt other large DSOs to follow suit with their own branded AI programs.
VideaHealth’s Expanding DSO Footprint
For VideaHealth, the Aspen deployment extends what has been a rapid period of enterprise growth. The company, founded by Florian Hillen, now serves more than 50,000 clinicians across 60+ DSOs, including eight of the ten largest dental support organizations in North America. The platform analyzes more than 500 million X-rays annually and holds FDA clearance for over 30 dental conditions, a regulatory milestone reached in January 2024.
VideaHealth raised a $40 million Series B in January 2025, led by Threshold Ventures, at a reported valuation of approximately $400 million.
“My sincerest hope is that the successful rollout of AI across the vast Heartland Dental supported footprint will help other DSOs recognize what is possible,” Hillen said in a recent statement. “With many DSOs whose scale is smaller, rollout is possible in a matter of weeks, not months.”
Hillen and Aspen Dental CEO Bob Fontana also co-founded the AI Leadership Council, an industry body aimed at advancing responsible AI adoption in dentistry.
A Pattern of Accelerating Deployments
The Aspen rollout does not exist in isolation. It follows Heartland Dental’s deployment of the same platform across 1,700+ supported practices in approximately 10 weeks during 2024 — a timeline that was itself considered remarkably fast at the time.
Aspen completed a comparable deployment across 1,100+ offices in roughly 60% of that time. And just two weeks after Aspen’s announcement, Great Expressions Dental Centers (210+ practices) completed its own VideaHealth rollout in only two weeks.
The compression in deployment timelines — from months to weeks — points to a maturing implementation playbook and growing organizational readiness across the DSO sector.
What This Signals
The pace of clinical AI adoption in organized dentistry has shifted decisively. What was a cautious pilot-and-evaluate cycle as recently as 2023 has given way to enterprise-speed rollouts that treat AI as operational infrastructure rather than experimental technology.
Several factors are driving the acceleration:
- Proven ROI: Pilot data from multiple DSOs — including Aspen’s 12% treatment acceptance lift — gives leadership teams the confidence to move quickly.
- Regulatory clarity: FDA clearances covering dozens of conditions have reduced compliance uncertainty.
- Mature integration: Vendors have refined their onboarding and IT integration processes through successive large-scale deployments.
- Competitive pressure: As more top-10 DSOs go live with clinical AI, holdouts face growing pressure to act.
VideaHealth currently holds a dominant position in clinical AI for large DSOs, but the market is far from settled. Competitors including Overjet, Pearl, and other diagnostic AI providers continue to compete for DSO contracts, while operational AI platforms such as TrueLark and Viva AI are expanding the definition of what “dental AI” means beyond the operatory and into the front office, patient communications, and practice analytics.
For DSO executives evaluating their AI strategy, the Aspen deployment offers a clear takeaway: the window between “considering AI” and “deploying AI” has narrowed dramatically. The question is no longer whether to adopt, but how quickly an organization can move from pilot to full-scale implementation.